en · de · es · fr · pt
semaglutide-notes.peptides3626.com › Topic › Peptide Background And Receptor Mechanism — Beginner to Advanced

Peptide Background And Receptor Mechanism — Beginner to Advanced

By Editorial Desk · published 2026-07-27 · last reviewed 2026-08-01 · Topic

A practical reference on Aib substitution: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.

Peptide Background and Receptor Mechanism

The primary target is the GLP-1 receptor, a class B G protein-coupled receptor expressed on pancreatic beta cells, in the gut, and in several brain regions. Receptor activation raises intracellular cyclic AMP, which potentiates glucose-dependent insulin secretion and lowers glucagon release when blood glucose is elevated. Signalling in the hypothalamus and brainstem is associated with reduced appetite and slower gastric emptying. Because the insulinotropic effect depends on prevailing glucose levels, the hypoglycaemic risk of the peptide alone is described as low in most study settings. The relative contribution of peripheral and central actions remains an active research question.

Large randomised trials in adults with type 2 diabetes and in adults with obesity have reported reductions in body weight and improvements in several cardiovascular risk markers. One outcome trial found a lower incidence of major adverse cardiovascular events in participants with diabetes and established cardiovascular disease. Gastrointestinal effects such as nausea and vomiting are the most frequently reported adverse events and often diminish over time. Changes in lean body mass during weight loss are an area of ongoing investigation. Effects in adolescents and in pregnancy are less well characterised, and current labelling advises against use during pregnancy.

Semaglutide Structure and Receptor Mechanism

Receptor activation follows the canonical Gs pathway: binding increases intracellular cyclic AMP, which promotes protein kinase A activity. In pancreatic beta cells this amplifies glucose-dependent insulin release, so secretion rises when blood glucose is high and changes little when it is low. The same signalling suppresses glucagon release from alpha cells and slows gastric emptying. Receptors in the hypothalamus and brainstem are thought to contribute to reduced appetite and lower energy intake. Which of these effects dominates clinical outcomes remains an area of active study.

Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1, a gut hormone released by intestinal L cells after food intake. The natural hormone acts on pancreatic and central receptors but is degraded within minutes by dipeptidyl peptidase-4 and other peptidases. Semaglutide belongs to the class of long-acting GLP-1 receptor agonists, a group distinguished by structural changes that slow breakdown and extend circulation time. Its development followed earlier short-acting analogues and reflects a general strategy in peptide drug design: preserve receptor activity while blocking proteolytic clearance.

Semaglutide at a glance

PropertyValueNotes
Molecular classAcylated GLP-1 receptor agonist31-residue synthetic peptide
Molecular formulaC187H291N45O59established for the free peptide
AppearanceWhite to off-white powderas supplied before formulation
SolubilityFreely soluble in wateraqueous buffers near neutral pH
Typical storage2 to 8 degrees Celsius, protected from lightpowder and solution forms differ in shelf life

Mechanism and Pharmacological Class

Serum protein binding dominates the pharmacokinetic profile. The attached chain associates strongly with albumin, shielding the peptide from enzymatic attack and slowing filtration by the kidney. This interaction extends the circulation half-life to roughly one week in humans, which supports weekly administration intervals. An oral version pairs the peptide with an absorption enhancer that transiently alters gastric epithelium, permitting limited uptake; bioavailability by that route is substantially lower than by injection.

Semaglutide belongs to the glucagon-like peptide-1 receptor agonist class, a group of synthetic peptides that imitate an incretin hormone released by intestinal L cells after food intake. Native GLP-1 circulates for only a few minutes because dipeptidyl peptidase-4 cleaves it rapidly. The hormone acts on pancreatic islets, the gastrointestinal tract, and several brain regions. Because the natural peptide is short-lived, development work concentrated on analogues that keep receptor activity while resisting enzymatic breakdown and renal clearance.

Related pages on this site

结构特征与受体作用机制

序列层面的改动同时解决了两个问题,即酶解稳定性与肾脏清除速度。天然 GLP-1 在循环中的半衰期仅约两分钟,主要被二肽基肽酶-4 迅速灭活。酰化侧链与白蛋白的可逆结合形成循环储库,使分子缓慢释放并持续激活受体。这种设计思路后来被广泛用于同类长效肽的开发,属于该类药物化学改造的典型范式。

Semaglutide 是一种经结构修饰的胰高血糖素样肽-1 类似物,其主链与内源性 GLP-1(7-36) 约有百分之九十四的序列一致性。第 8 位丙氨酸被 α-氨基异丁酸取代,使二肽基肽酶-4 无法识别原有切割位点。第 34 位赖氨酸换为精氨酸,进一步降低酶解速率。第 26 位赖氨酸经间隔基连接一条含十八个碳的二酸脂肪链,该侧链赋予分子与血浆白蛋白结合的能力。

该分子作为 GLP-1 受体的选择性激动剂发挥作用,受体属于 B 类 G 蛋白偶联受体家族,激活后经 Gs 通路提升细胞内环腺苷酸水平。在胰腺 β 细胞,信号促进葡萄糖依赖性的胰岛素释放,血糖偏低时该作用明显减弱。在胰岛 α 细胞,胰高血糖素分泌受到抑制。中枢神经系统与胃肠道同样存在受体表达,相应信号参与食欲调节以及胃排空速率的降低。

Handling, Storage, and Analytical Verification

Stability studies examine how temperature, pH, and moisture influence degradation rates over time. In aqueous solution, hydrolysis and deamidation accelerate as pH moves away from mildly acidic conditions. Light exposure and residual metal ions can also trigger oxidation of susceptible residues. Accelerated aging at elevated temperature is used to estimate shelf life, though extrapolation to room temperature carries uncertainty because individual degradation pathways do not always scale predictably.

Lyophilized semaglutide powder is typically held at minus twenty degrees Celsius for long-term storage. At that temperature, solid-state degradation reactions proceed slowly and the peptide remains intact for extended periods. Repeated freeze-thaw cycles are best avoided because they promote aggregation and can shift the proportion of monomeric peptide present. Working aliquots are often prepared so that each portion is thawed only once, and desiccant is placed inside the vial to limit moisture uptake.

Identity and purity are usually assessed by reverse-phase high-performance liquid chromatography coupled to mass spectrometry. Retention time and observed mass are compared against a reference standard run under identical conditions. Impurity profiles reveal deamidation products, oxidized methionine variants, and truncated fragments that arise during synthesis or storage. Peptide mapping through enzymatic digestion confirms the primary sequence, while amino acid analysis offers an independent check on overall composition.

Further detail

==== GBA gene ==== The GBA gene is associated with lysosome storage and autophagy. GBA encodes the enzyme glucocerebrosidase (GCase), necessary for breaking down glucosylceramide (GlcCer). Mutations in GBA can cause modifications in GCase protein structure, decreases in GCase activity and protein levels, and the accumulation of GlcCer in the cell. Approximately 5–15% of PD patients have mutations in the GBA gene. Mendelian genetics are not strictly observed in GBA mutations in PD. Both gain-of-function and loss-of-function GBA mutations are associated with increased risk of PD. GBA is one of a number of pleiotropic genes which have multiple effects in the body, that have been linked to PD risk. Mutations in GBA1 can cause either complete loss‐of‐function and the lysosomal disorder Gaucher's disease, or partial loss‐of‐function with an increased risk for PD. Mutations in EPG5 are implicated in a range of dysfunctions, from severe (Vici syndrome), to moderate (atypical parkinsonism) and mild (typical PD). Microdeletions at 22q11.2 have been variously linked to PD, schizophrenia, and DiGeorge syndrome.

In consultation with a physician, usage of herbal remedies should be clarified, as some herbal remedies have the potential to cause adverse drug interactions when used in combination with various prescription and over-the-counter pharmaceuticals, just as a customer should inform a herbalist of their consumption of actual prescription and other medication. For example, dangerously low blood pressure may result from the combination of a herbal remedy that lowers blood pressure together with prescription medicine that has the same effect. Some herbs may amplify the effects of anticoagulants. Certain herbs as well as common fruit interfere with cytochrome P450, an enzyme critical to much drug metabolism. In a 2018 study, the FDA identified active pharmaceutical additives in over 700 analyzed dietary supplements sold as "herbal", "natural" or "traditional". The undisclosed additives included "unapproved antidepressants and designer steroids", as well as prescription drugs, such as sildenafil or sibutramine.

The rearmament period just before World War II saw a big expansion in the number of Royal Ordnance Factories (ROFs), which were British government-owned. However, due to shortages of management resources some ROFs were run as agency factories; and J. Lyons and Co. ran at least one, ROF Elstow. The management and stock control systems needed in the ROFs, in respect of control of raw materials and "perishable" finished products, were somewhat similar to those used in the catering business; and J. Lyons was ideally suited to this task. They do not appear to have any involvement in managing these after 1945, when the ROFs started to run down.

Folgers is an American brand of coffee produced and sold in the United States, with additional distribution in Asia, Canada and Mexico. It forms part of the food and beverage division of the J.M. Smucker Company. Folgers roasts its coffee in New Orleans.

=== Variation === The size of the pancreas varies considerably. Several anatomical variations exist, relating to the embryological development of the two pancreatic buds. The pancreas develops from these buds on either side of the duodenum. The ventral bud rotates to lie next to the dorsal bud, eventually fusing. In about 10% of adults, an accessory pancreatic duct may be present if the main duct of the dorsal bud of the pancreas does not regress; this duct opens into the minor duodenal papilla. If the two buds themselves, each having a duct, do not fuse, a pancreas may exist with two separate ducts, a condition known as a pancreas divisum. This condition has no physiologic consequence. If the ventral bud does not fully rotate, an annular pancreas may exist, where the pancreas encircles part or all of the duodenum. This may be associated with duodenal atresia.

Sources: en.wikipedia.org

Background from the literature

Much of the literature, however, suggests a curvilinear or even quadratic relationship between spatial performance and circulating testosterone, where both hypo- and hypersecretion (deficient- and excessive-secretion) of circulating androgens have negative effects on cognition.

== Uses == Hydroquinone has a variety of uses principally associated with its action as a reducing agent that is soluble in water. It is a major component in most black and white photographic developers for film and paper, where, with the compound metol, it reduces silver halides to elemental silver. There are various other uses associated with its reducing power. As a polymerisation inhibitor, exploiting its antioxidant properties, hydroquinone prevents polymerization of acrylic acid, methyl methacrylate, cyanoacrylate, and other monomers that are susceptible to radical-initiated polymerization. By acting as a free radical scavenger, hydroquinone serves to prolong the shelf life of light-sensitive resins such as preceramic polymers. Hydroquinone can lose a hydrogen cation from both hydroxyl groups to form a diphenolate ion. The disodium diphenolate salt of hydroquinone is used as an alternating comonomer unit in the production of the polymer PEEK.

=== In the West Pacific === Native aluminium has been reported also in cold seeps in the northeastern continental slope of the South China Sea and Chen et al. (2011) have proposed a theory of its origin as resulting by reduction from tetrahydroxoaluminate Al(OH)4− to metallic aluminium by bacteria.

In immunology, an adjuvant is a substance that increases or modulates the immune response to a vaccine. The word "adjuvant" comes from the Latin word adiuvare, meaning to help or aid. "An immunologic adjuvant is defined as any substance that acts to accelerate, prolong, or enhance antigen-specific immune responses when used in combination with specific vaccine antigens." In the early days of vaccine manufacture, significant variations in the efficacy of different batches of the same vaccine were correctly assumed to be caused by contamination of the reaction vessels. However, it was soon found that more scrupulous cleaning actually seemed to reduce the effectiveness of the vaccines, and some contaminants actually enhanced the immune response. There are many known adjuvants in widespread use, including potassium alum, various plant and animal derived oils and virosomes.

=== Evidence === At trial, the prosecution presented evidence from parents, clinicians and expert witnesses. The mother of Baby E testified that she had heard her son cry and found blood around his mouth while Letby was present; Letby attributed the blood to a nasogastric tube. Baby E died later that day. Letby subsequently sent a sympathy card to the family, photographs of which were later found on her phone. The court also heard that she had been advised more than once not to enter a room where bereaved parents were grieving. Prosecutors cited text messages sent by Letby to colleagues, which they said showed inappropriate interest in clinical events. Messages included offers to take additional intensive‑care shifts shortly after deaths or collapses, expressions of frustration when not allocated to intensive‑care rooms, and comments about fate following a series of deaths. The court also heard that Letby had searched for the families of several infants on Facebook, sometimes on anniversaries or significant dates. She told the jury this reflected general curiosity and frequent phone use. Consultants testified that they believed suspicious incidents began after Letby qualified to work in intensive care in 2015 and that the pattern of collapses shifted after she was moved from night to day shifts in 2016. One consultant said he had found Letby standing over a deteriorating infant in February 2016 and believed she had not intervened promptly; the infant survived.

Sources: en.wikipedia.org

Reference notes

In 1943, the Nobel committee received a single nomination for the Nobel Prize in Physiology or Medicine for Fleming and Florey from the British biochemist Rudolph Peters. The secretary of the Nobel committee, Göran Liljestrand, made an assessment of Fleming and Florey in the same year, but little was known about penicillin in Sweden at the time, and he concluded that more information was required. The following year, there was one nomination for Fleming alone and one for Fleming, Florey and Chain. Liljestrand and Nanna Svartz, the professor of medicine at the Karolinska Institute, considered their work, and while both judged Fleming and Florey equally worthy of a Nobel Prize, the Nobel committee was divided, and decided to award the prize that year instead to Joseph Erlanger and Herbert S. Gasser "for their discoveries relating to the highly differentiated functions of single nerve fibres". There were a large number of nominations for Florey and Fleming or both in 1945, and one for Chain, from Liljestrand, who nominated all three. Liljestrand noted that thirteen of the first sixteen nominations that came in mentioned Fleming, but only three mentioned him alone. This time evaluations were made by Liljestrand, Sven Hellerström and Anders Kristenson, who endorsed all three. There were rumours that the committee would award the prize to Fleming alone, or half to Fleming and one-quarter each to Florey and Chain. Fulton and Dale lobbied for the award to be given to Florey.

Petrov underwent intense questioning by his superiors about his actions. Initially, he was praised for his decision. General Yuri Votintsev, then commander of the Soviet Air Defense's Missile Defense Units, who was the first to hear Petrov's report of the incident (and the first to reveal it to the public in 1998), stated that Petrov's "correct actions" were "duly noted". Petrov himself stated he was initially praised by Votintsev and was promised a reward, but recalled that he was also reprimanded for improper filing of paperwork with the pretext that he had not described the incident in the military diary. He received no reward. According to Petrov, this was because the incident and other bugs found in the missile detection system embarrassed his superiors and the influential scientists who were responsible for it, so that if he had been officially rewarded, they would have had to be punished. He was reassigned to a less sensitive post, took early retirement (although he emphasized that he was not "forced out" of the army, as is sometimes claimed by Western sources), and suffered a nervous breakdown. Oleg Kalugin, a former KGB chief of foreign counter-intelligence who knew Soviet leader Yuri Andropov well, said that Andropov's distrust of American leaders was profound. It was conceivable that if Petrov had declared the satellite warnings valid, such an erroneous report could have provoked the Soviet leadership into becoming bellicose. Kalugin said: "The danger was in the Soviet leadership thinking, 'The Americans may attack, so we better attack first.'"

Quantum chemical calculations of molecular and supermolecular systems, Ab initio Monte Carlo and MD simulations of liquids / solutions, Electrolyte solution structure, Ultrafast Dynamics of solutes, Molecular Modelling of biomolecules and drugs, QSAR / QSPR, Chemical Evolution of Peptides/ Proteins and Origin of Life

ATGL activity is also impacted by the negative regulator of lipolysis, G0/G1 switch gene 2 (G0S2). When expressed, G0S2 acts as a competitive inhibitor in the binding of CGI-58. Fat-specific protein 27 (FSP-27) (a.k.a. CIDEC) is also a negative regulator of lipolysis. FSP-27 expression is negatively correlated with ATGL mRNA levels.

== Other Activities == 1972–1975 – Associate Member, Viking Lander Science Team, NASA 1979–1982 – – Member, Committee on Response Strategies to Unusual Chemical Hazards, Assembly of Life Sciences, National Research Council 1982 – U.S. Coordinator, U.S.-Japan Joint Seminar on “Microcolumn Separation Methods and their Ancillary Techniques,” Honolulu, Hawaii 1980–1984 – Member, Advisory Committee to the Analytical Chemistry Division, Oak Ridge National Laboratory 1986 – Instructor, ACS Short Course on Supercritical Fluid Chromatography 1988, 1990 – Organizing Committee, International Symposium, “Microcolumn Separation Methods,” Bloomington, IN and Aronberg, Sweden 1988, 1991 – Scientific Committee, International Symposium, “HPLC 88” and “HPLC 92” 1977–Pres. – Instructor, ACS Short Course on Capillary Gas Chromatography 1978–Pres. – ACS Lecture Tour Speaker 1990–Pres. – Scientific Committee, International Symposia on Capillary Chromatography 1994 – Scientific Committee, Glycobiology: Analytical Methods 2003 – Member of the Center for the Integrative Study of Animal Behavior, Indiana University 2004 – Member of the Indiana University Cancer Center, IU School of Medicine .

Sources: en.wikipedia.org

Frequently asked questions

How does semaglutide differ from native GLP-1?

Native GLP-1 is degraded within minutes by dipeptidyl peptidase-4 and neutral endopeptidases. Semaglutide carries a non-natural amino acid at position eight that blocks that cleavage, and a fatty diacid side chain that binds albumin. The result is a much longer duration of action than the native hormone.

What role does albumin binding play?

The fatty diacid chain associates strongly with serum albumin, which keeps the peptide in circulation and shields it from rapid renal clearance. Bound peptide is released gradually, producing a sustained receptor signal. This mechanism also reduces the peak-to-trough variation seen with shorter-acting analogues.

Which questions about the mechanism remain open?

The balance between peripheral receptor activation and signalling in the central nervous system is not fully resolved. The extent to which slowed gastric emptying accounts for reduced energy intake, compared with direct effects on appetite circuits, is debated. Long-term effects on lean mass and on tissues outside the gut and brain are still under study.

How does semaglutide differ from native GLP-1?

Native GLP-1 is a short-lived peptide cleared within one to two minutes by dipeptidyl peptidase-4 and related enzymes. Semaglutide keeps the receptor-binding backbone but adds substitutions and a lipid chain. These changes block the main cleavage site and allow reversible albumin binding, extending the half-life to roughly 165 hours.

Network